STREAM Clinical Study First To Include Bedaquiline To Test Shortened Treatment Regimens For Multidrug-Resistant TB In Phase III Trial

Read more

From 2 Years To 6 Months – New Hope For Shorter MDR-TB Treatment

Re-posted from the Vital Strategies blog published on February 4, 2016 Patients diagnosed with multi-drug resistant tuberculosis (MDR-TB)... Read more